Literature DB >> 25771496

The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane.

Patricia M Day1, Cynthia D Thompson2, Douglas R Lowy2, John T Schiller2.   

Abstract

To understand and compare the mechanisms of murine and human PV infection, we examined pseudovirion binding and infection of the newly described MusPV1 using the murine cervicovaginal challenge model. These analyses revealed primary tissue interactions distinct from those previously described for HPV16. Unlike HPV16, MusPV1 bound basement membrane (BM) in an HSPG-independent manner. Nevertheless, subsequent HSPG interactions were critical. L2 antibodies or low doses of VLP antibodies, sufficient to prevent infection, did not lead to disassociation of the MusPV1 pseudovirions from the BM, in contrast to previous findings with HPV16. Similarly, furin inhibition did not lead to loss of MusPV1 from the BM. Therefore, phylogenetically distant PV types differ in their initial interactions with host attachment factors, but initiate their lifecycle on the acellular BM. Despite these differences, these distantly related PV types displayed similar intracellular trafficking patterns and susceptibilities to biochemical inhibition of infection. Published by Elsevier Inc.

Entities:  

Keywords:  Basement membrane (BM); Cervicovaginal challenge model (CVC); Endocytosis; Extracellular matrix (ECM); Furin; HPV16; Heparan sulfate proteoglycan (HSPG); Heparin; MmuPV1; MusPV1

Mesh:

Substances:

Year:  2015        PMID: 25771496      PMCID: PMC4437838          DOI: 10.1016/j.virol.2015.02.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  54 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  The papillomavirus major capsid protein L1.

Authors:  Christopher B Buck; Patricia M Day; Benes L Trus
Journal:  Virology       Date:  2013-06-22       Impact factor: 3.616

4.  In vivo mechanisms of vaccine-induced protection against HPV infection.

Authors:  Patricia M Day; Rhonda C Kines; Cynthia D Thompson; Subhashini Jagu; Richard B Roden; Douglas R Lowy; John T Schiller
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

5.  Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  Methods Mol Med       Date:  2005

6.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating.

Authors:  Jessica L Smith; Samuel K Campos; Angela Wandinger-Ness; Michelle A Ozbun
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

9.  The organellular chloride channel protein CLIC4/mtCLIC translocates to the nucleus in response to cellular stress and accelerates apoptosis.

Authors:  Kwang S Suh; Michihiro Mutoh; Kunio Nagashima; Ester Fernandez-Salas; Lindsay E Edwards; Daniel D Hayes; John M Crutchley; Keith G Marin; Rebecca A Dumont; Joshua M Levy; Christina Cheng; Susan Garfield; Stuart H Yuspa
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

10.  Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.

Authors:  Jeffrey N Roberts; Christopher B Buck; Cynthia D Thompson; Rhonda Kines; Marcelino Bernardo; Peter L Choyke; Douglas R Lowy; John T Schiller
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  8 in total

1.  Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.

Authors:  Patricia M Day; Andrea S Weisberg; Cynthia D Thompson; Michelle M Hughes; Yuk Ying Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

2.  Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.

Authors:  Patricia M Day; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  Passive Immunization with a Single Monoclonal Neutralizing Antibody Protects against Cutaneous and Mucosal Mouse Papillomavirus Infections.

Authors:  Sarah A Brendle; Jingwei Li; Nancy M Cladel; Karla K Balogh; Jennifer Booth; Debra A Shearer; Vonn Walter; Song Lu; Neil D Christensen; Danielle Covington; Jake DeBroff; Janice Milici; Yusheng Zhu; Raphael Viscidi; Jiafen Hu
Journal:  J Virol       Date:  2022-08-03       Impact factor: 6.549

4.  A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus.

Authors:  Renee E King; Andrea Bilger; Josef Rademacher; Ella T Ward-Shaw; Rong Hu; Paul F Lambert; Susan L Thibeault
Journal:  Viruses       Date:  2022-05-08       Impact factor: 5.818

Review 5.  Rodent Papillomaviruses.

Authors:  Aayushi Uberoi; Paul F Lambert
Journal:  Viruses       Date:  2017-11-27       Impact factor: 5.048

6.  Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.

Authors:  Carla Cerqueira; Cynthia D Thompson; Patricia M Day; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  Mol Ther Methods Clin Dev       Date:  2017-04-19       Impact factor: 6.698

Review 7.  Mus musculus Papillomavirus 1: a New Frontier in Animal Models of Papillomavirus Pathogenesis.

Authors:  Megan E Spurgeon; Paul F Lambert
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

8.  An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.

Authors:  Tao Wei; Darya Buehler; Ella Ward-Shaw; Paul F Lambert
Journal:  mBio       Date:  2020-05-12       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.